PA550276

TFF2 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PA550276-Each-of-1 In Stock ₹ 46,502.50

PA550276 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

TFF2

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Tff2

Gene Alias

mSP; pancreatic spasmolytic polypeptide; PSP; SML1; SP; spasmolysin; Spasmolytic polypeptide; spasmolytic protein 1; Tff2; Trefoil factor 2; trefoil factor 2 (spasmolytic protein 1)

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

7032

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin)

Concentration

1.2 mg/mL

Formulation

PBS with 40% glycerol and 0.05% sodium azide; pH 7.4

Gene Accession No.

Q03403

Gene Symbols

Tff2

Immunogen

Fusion protein corresponding to a region derived from internal residues of human trefoil factor 2

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PA550382

--

Img

Thermo Scientific

PA550530

--

Img

Thermo Scientific

PA550703

--

Img

Thermo Scientific

PA550579

--

Img

Thermo Scientific

PA550225

--

Img

Thermo Scientific

PA550724

--

Img

Thermo Scientific

PA550811

--

Img

Thermo Scientific

PA550272

--

Description

  • The antibody detects endogenous levels of total SP / TFF2 protein
  • Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing and protection of the gastrointestinal epithelia
  • These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain
  • SP (spasmolytic polypeptide), also designated Trefoil factor 2 (TFF2) precursor, is a trefoil protein that functions to inhibit gastrointestinal motility and gastric acid secretion
  • SP may also act as a structural component of the gastric mucus, possibly by stabilizing glycoproteins in the mucus gel through interactions with carbohydrate side chains
  • A downregulation of SP expression is associated with primary gastric cancer, and a progressive loss of this protein is likely to be involved in the early stage of the multi-step gastric carcinogenesis pathway.